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ABSTRACT 
Objective: The purpose of this study was to assess the effects an acute dosage of different 
flavanol concentrations in a dark chocolate bar has on physiological parameters during 
steady state (SS) and incremental exercise.  
Methods: In a double-blind, randomised, crossover study, fifteen healthy participants with 
a mean ± SD age of 30 ± 7 years; stature 176.8 ± 8.6 cm and body mass 80.3 ± 8.4 kg 
supplemented with high flavanol (HF) (1060mg), moderate flavanol (MF) (746mg), low 
flavanol (LF) (406mg) or a control (CON) (88mg) chocolate bar (~34 grams), 2 hours prior 
to 40 minutes of SS cycling (80% gas exchange threshold) followed by an incremental test 
to volitional fatigue. During the SS cycle oxygen consumption (?̇?𝑉𝑂𝑂2), respiratory exchange 
ratio (RER) and heart rate (HR) were continuously monitored. Plasma samples were 
collected prior to commencing exercise to determine nitrate (NO3-) and nitrite (NO2-) levels 
under each condition.  
Results: There was no observed effect between flavanol concentrations on ?̇?𝑉𝑂𝑂2, RER and 
HR during SS cycling (P>0.05).  ?̇?𝑉𝑂𝑂2 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝, peak power, HR peak and RER peak also did 
not significantly differ between conditions (P>0.05). There was a small trend for higher 
plasma NO2- levels following higher flavanol concentration, however this did not reach 
statistical significance (P>0.05).  
Conclusion: Acute supplementation with cocoa of differing flavanol concentrations does 
not appear to have any effect on exercise and performance. It is plausible that longer 
flavanol supplementation periods might have greater accumulative effects and thus may 
potentially elicit a larger effect. 
Keywords: dark chocolate; nitric oxide; flavanol; nitrite; cycling. 
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ABBREVATIONS  
BP  Blood pressure  
CF  Cocoa flavanols 
CON  Control 
DC  Dark chocolate 
EC  (-)-epicatechin  
eNOS  Endothelial nitric oxide synthase 
FMD  Flow mediated dilation 
GET  Gas exchange threshold 
HF  High flavanol 
HR  Heart rate  
LF  Low flavanol 
MF  Moderate flavanol 
NO  Nitric oxide 
NO2-  Nitrite  
NO3-  Nitrate  
NOS  Nitric oxide synthase 
RER  Respiratory exchange ratio  
SS  Steady state  
TT  Time trials 
VCO2  Volume of exhaled carbon dioxide 
VE  Ventilation 
?̇?𝑉𝑂𝑂2  Volume of oxygen consumption 






Regular consumption of cocoa particularly rich in flavanols has been associated with a 
reduction in the risk of cardiovascular morbidity, mortality and can also contribute towards 
the prevention of other chronic diseases (Al-Dashti et al. 2018; Lovegrove et al. 2017). The 
consumption of cocoa flavanols (CF) has been reported to induce acute and sustained 
improvements in endothelium-dependent vasodilation in healthy participants and 
especially in those with an increased cardiovascular risk (Balzer et al. 2008; Engler et al. 
2004; Fisher et al. 2003; Fisher et al. 2012; Grassi et al. 2005a; Grassi et al. 2005b; Sudarma 
et al. 2011; Taubert et al. 2007). These effects have been ascribed, at least in part, to CFs 
capacity to enhance the bioavailability and bioactivity of nitric oxide (NO). The monomeric 
portion of CF, (-)-epicatechin (EC) and catechin and to a lesser extent the polymeric, 
procyanidins, are linked to blood pressure and vasoactive effects (Schroeter et al. 2006). 
Modern processing of cacao diminishes flavanol content and often negatively influences 
the EC/catechin ratio (Hurst et al. 2011). Moreover, the optimal quantity of chocolate 
required to elicit improvements in vasodilation has not been established, with studies 
supplementing between 6.3g/day to 100g/day of chocolate (Engler et al. 2004; Grassi et al. 
2005a; Sudarma et al. 2011; Taubert et al. 2007). Thus, it is crucial to compare the 
concentrations of flavanol rather than simply the quantity of chocolate administered in 
clinical trials.  
In a recent review investigating the effects of CF on blood pressure, flavanol enriched 
cocoa concentrations ranged between 30 to 1218mg (mean = 670mg), with trials 
supplementing for between two hours and eighteen weeks. Despite the vascular properties 
of CF being linked with the formation of endothelial NO, many studies consistently lack 
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reporting NO biomarkers, thus, making it challenging to determine the optimal CF 
concentration which elicits an optimal vascular effect.   
Given that NO mediates blood flow and mitochondrial respiration during exercise, 
it has been postulated that enhanced NO production following CF supplementation may 
promote greater oxygen and nutrient delivery to active muscles, as well as improve 
mitochondrial efficiency, leading to improvement in the tolerance to steady state (SS) 
exercise. In mice, EC consumption has been reported to increase exercise performance and 
muscle fatigue following enhanced capillarity (Nogueira et al. 2011). However, the 
research within humans is limited; Decroix et al. (2017) found EC peaked two hours after 
a single acute dose of 900mg of CF and resulted in a significantly higher peak power during 
the first of two time trials (TT).  Overall completion times tended to be quicker, although 
this did not reach statistical significance (P=0.09).  Another study used acute 
supplementation of dark chocolate (DC) (100g containing 246.8mg of flavanol) and 
demonstrated a better maintenance of plasma glucose (Davison et al. 2012) over 2.5h of 
cycling (~60% ?̇?𝑉𝑂𝑂2 𝑚𝑚𝑝𝑝𝑚𝑚, ?̇?𝑉𝑂𝑂2 𝑚𝑚𝑝𝑝𝑚𝑚: 53.1 ± 1.9 ml/kg/min), however performance was not 
measured.  Intriguingly chronic DC consumption of 40g (twice daily, total of 197.2mg of 
flavanol per day) for two weeks resulted in a 21% increase in plasma free fatty acids during 
prolonged exercise compared with an iso-fat–calorie–carbohydrate control (Allgrove et al. 
2011), but these effects were not associated with enhanced exercise performance. More 
recently, we demonstrated two-weeks consumption of DC (259mg flavanol) led to a 
significant increase in gas exchange threshold (GET) and time trial performance (Patel et 
al. 2015), but the study design was limited by the lack of an appropriate placebo condition 
and our results should be viewed with caution.  
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To date, there is limited information on the optimal concentration of flavanol needed to 
elicit changes in NO bioavailability and whether CFs have an ergogenic effect on 
moderately trained participants during SS and incremental intensity exercise. Moreover, as 
most athletes would arguably prefer to use an acute supplementation strategy rather than 
chronic and EC peaks after two hours, the present study aimed to investigate whether acute 
(2 hours pre-exercise) supplementation with chocolate containing high to low 
concentrations of flavanol (88mg, 406mg, 746mg and 1060mg) could have an effect on 
exercise performance. We hypothesise that higher concentrations of flavanol will have an 




Fifteen healthy participants (10 males and 5 females; with a mean ± SD, age of 30 ± 7; 
stature 176.8 ± 8.6cm and body mass 80.3 ± 8.4 kg) were recruited to participate in the 
present study. All participants provided written informed consent, completed health 
screening and a physical activity questionnaire (PARQ). The group comprised 
recreationally active participants who regularly cycled for pleasure and the occasional 
sportive (?̇?𝑉𝑂𝑂2 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝; Males 51.1 ± 3.5, Females 41.6 ± 5.5 ml/kg/min). Participants were 
advised to maintain the same level of physical activity throughout the duration of the study.  
Participants were excluded from the study if they met any of the following criteria: (1) <18 
years or > 50years, (2) hypertension, (3) cardiovascular disease, (4) smokers or history of 
smoking and (5) habitual supplementation. The study commenced after approval by the 
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Ethics Committee at Kingston University (Ethics code 1415/005) and with the 1964 




Participants were asked to maintain their normal diet and refrain from alcohol, vitamin 
supplements and anti-inflammatory products. Throughout the intervention period 
participants were asked to refrain from consuming any form of chocolate. At no given time 
were participants advised to reduce daily fruit and vegetable consumption between 
conditions. A list of high nitrate and polyphenolic fruits and vegetables was given to 
participants to avoid and replace with appropriate substitutes for the 24h prior to exercise 
testing. Participants were required to follow a similar diet throughout the intervention and 
replicate their diet the day prior to testing. All tests were carried out following a 12h 
overnight fast between 7-10 am. In most instances, participants consumed their DC 
condition on-site. For those participants that were unable to attend the laboratory 2hrs prior 
to testing, they were provided with the DC bar the night before for consumption at a precise 
time. Participants were then contacted at the time of consumption via telephone to ensure 
full compliance with the supplementation strategy. All participants self-reported adherence 





Resting blood pressure (BP) was measured on all supplementation visits using an 
automated sphygmomanometer (Omron M4 Digital, Omron Healthcare, Wegelaan, 
Netherlands). Participants were rested supine for a minimum of 10minutes before three 
measurements were taken, each separated by 3 minutes, with the mean value being taken. 
 
Plasma nitrite (NO2-) and nitrate (NO3-) analysis 
Blood plasma samples were drawn using a 21g butterfly needle into EDTA BD vacutainer 
2h following supplementation, immediately prior to exercise testing. Samples were 
centrifuged at 4000rcf at 4°C for 10 minutes within 3 minutes of collection. The plasma 
was subsequently extracted and immediately flash frozen at -80°C for later analysis. 
Analysis of NO3- and NO2- was performed via ozone-based chemiluminescence (Rogers et 
al. 2005)  
 
Exercise protocols 
Participants were asked not to perform intense exercise in the 48h prior to testing and 
refrain from any exercise in the 24h preceding the tests. The exercise protocols involved 
five separate visits to the laboratory. On the first visit participants performed an incremental 
test to failure to determine ?̇?𝑉𝑂𝑂2 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 and gas exchange threshold (GET). The incremental 
test comprised a 5-minute warm up at 50W at a self-selected cadence (between 60 – 90 
rpm) after which the work rate was increased at 30W min-1 until the participants reached 
volitional failure or the cadence fell below 50 rpm. Pulmonary gas exchange was collected 
breath-by-breath (Oxycon Pro, VIASYS GmbH, Eric Jaeger, Hoechberg, Germany) during 
the incremental tests and averaged over consecutive 15-s periods and used to establish gas 
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exchange threshold (GET). Gas exchange threshold was determined as the work rate 
corresponding at the precise cross over, at which VE/VO2 continually exceed VE/VCO2.  
 
A double-blinded randomised crossover design was employed, which required four further 
visits to the laboratory, each separated by a minimum of a 7 day wash out period. 
Participants were randomly assigned acute (2hour) supplementation with one of four 
possible dark chocolate (DC) supplementation conditions.  Bars of chocolate were 
specifically manufactured to the following specifications (~34g); high flavanol (HF, 
1060mg), moderate flavanol (MF, 746mg), Low flavanol (LF, 406mg) or a control (CON, 
88mg). The DC was calorifically matched and contained similar levels of theobromine, the 
only variation between conditions were the cocoa powder flavanol concentration used to 
make up each DC condition.  
 
The full exercise protocol comprised a two-minute incremental warmup to a constant work 
rate corresponding to 80% of their GET and which was maintained for forty minutes. This 
was immediately followed by ten minutes of static seated rest (recovery phase), during 
which blood pressure was measured at the third and fifth minute.  ?̇?𝑉𝑂𝑂2, RER and HR were 
continuously measured and averaged over the SS cycle and the recovery phase. The 
exercise test was completed with an incremental test to failure, as conducted during visit 
one. ?̇?𝑉𝑂𝑂2 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 was taken as the highest 30-s average value attained before the participant 
reached failure. The power output reached at the point of fatigue was recorded as the peak 





Statistical analysis  
Statistical analysis was conducted using the Statistical Package for Social Sciences (SPSS 
v.21). To examine for difference between the four conditions, dependent variables were 
first analysed for normality. As all data met parametric assumptions, a within subject 
repeated measure analysis of variance (ANOVA) was utilised. Significance was accepted 
at P<0.05. When significance was found a post-hoc Tukey for within conditions was 
employed to identify the differences that occurred.  
 
RESULTS 
Steady state and incremental cycling 
?̇?𝑉𝑂𝑂2, RER and HR values in response to steady state cycling after consumption of all 
conditions are reported in Table 1, there was no significant difference between conditions 
(P>0.05). Furthermore, during the incremental cycle test, ?̇?𝑉𝑂𝑂2 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝, peak power, HR peak 
and RER max did not significantly differ between all conditions (P>0.05). 
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Table 1. Pulmonary gas exchange measures during SS and incremental cycling after HF, 
MF, LF and CON intake. 
Values are means ± SD Note. SS= steady state, RER = respiratory exchange ratio, HR = heart rate, HF 
= high flavanol, MF = moderate flavanol, LF = low flavanol and CON = control. 
 
Post exercise blood pressure and cardiorespiratory measurements 
Systolic and diastolic blood pressure was assessed at the third and fifth minute during the 
recovery phase immediately after SS cycling for each condition (Table 2). There were no 
significant differences between conditions for systolic or diastolic blood pressure in the 
third and fifth minute of the resting recovery phase (P>0.05). There was no significant 
difference between conditions for ?̇?𝑉𝑂𝑂2, RER or HR values during the recovery phase 
















Steady state exercise 
?̇?𝑉𝑂𝑂2 (Lmin-1) 1.84 ± 0.66 1.84 ± 0.68 1.85 ± 0.66 1.84 ± 0.64 >0.05 
RER 0.89 ± 0.03 0.9 ± 0.03 0.89 ± 0.03 0.89 ± 0.02 >0.05 
HR (BPM) 
 




?̇?𝑉𝑂𝑂2 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 (Lmin-1) 3.95 ± 0.97 3.99 ± 1.12 4 ± 1.12 3.86 ± 1 >0.05 
Peak power (W) 280 ± 43 278 ± 51 284 ± 52 274 ± 48 >0.05 
RER max 1.22 ± 0.05 1.22 ± 0.04 1.21 ± 0.05 1.21 ± 0.03 >0.05 
HR peak (BPM) 180 ± 4 180 ± 5 180 ± 5 180 ± 4 >0.05 
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Table 2. V̇O2 and HR responses averaged over the ten-minute recovery phase. Mean 
changes in SBP and DBP assessed at the third and fifth minute during the recovery phase 











?̇?𝑉𝑂𝑂2 (Lmin-1) 0.70 ± 0.2 0.7 ± 0.21 0.71 ± 0.21 0.71 ± 0.19 >0.05 
HR (BPM) 67 ± 5 66 ± 5 68 ± 5 67 ± 5 >0.05 
SBP (mmHg)     
         3rd min 
         5th min        
 
143 ± 4 
133 ± 3 
 
140 ± 4 
132± 4 
 
140 ± 4 
133 ± 5 
 
139 ± 5 




DBP (mmHg)     
          3rd min 
          5th min        
 
86 ± 4 
83 ± 5 
 
85 ± 4 
82± 5 
 
86 ± 4 
82 ± 5 
 
87 ± 4 




Values are means ± SD. Note. RER = respiratory exchange ratio; DBP = diastolic blood pressure, SBP 
= systolic blood pressure, HR = heart rate, HF = high flavanol, MD = moderate flavanol, LF = low 
flavanol and CON = control. 
 
Resting blood pressure 
Systolic blood pressure following consumption of the control tended to be higher, 
although this was not necessarily in a dose dependent manner (P=0.1) (refer to Fig. 1).  
There were no clear trends observed between conditions for diastolic Blood Pressure 
(DBP) (P=0.19) (refer to Fig. 1). Mean arterial pressure (not presented) was not 
significantly different between conditions (P=0.35). 
Pre-exercise plasma NO2- and NO3-  
Pre-exercise plasma NO3- and NO2- levels were measured 2h after supplementation, with 
no significant difference between conditions (P>0.05), (Fig. 2).  
 
DISCUSSION 
The main finding of this study was acute supplementation with dark chocolate (DC) of 
differing flavanol concentrations 2h prior to exercise has no ergogenic effect on exercise 
performance in recreationally trained participants.  Notably, plasma nitrite (NO2-) tended 
to be greater after higher flavanol dosages (refer to Fig. 2), although this did not reach the 
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statistical probability threshold. Similarly, systolic blood pressure tended to be lower after 
higher flavanol dosages, but also did not reach the threshold for significance. 
 
Effects of dietary flavanol supplementation on the physiological responses to maximal 
and submaximal exercise.  
In this study acute intake of different levels of CFs did not alter ?̇?𝑉𝑂𝑂2, RER or HR during 
submaximal SS cycling. Furthermore, acute supplementation with CFs did not have an 
effect on ?̇?𝑉𝑂𝑂2 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝, peak power, HR peak and RER max during maximal cycling. This 
suggests that acute flavanol intake of concentrations between 88mg and 1060mg taken 2h 
prior to exercise has no ergogenic effect on performance in recreationally trained 
participants. These findings are in line with those of Davison et al. (2012) , who observed 
no change in HR, RER and V̇O2 during cycling for 2.5 h of cycling at 60% V̇O2 max after 
supplementation with 247mg flavanol. Similarly, Stellingwerff et al. (2014) reported no 
change in performance or recovery following 240mg of flavanols compared to a cocoa-
depleted control. However, this was most likely because EC metabolites had appreciably 
decreased to 65% of peak concentrations on commence of the 15min TT, thus NO levels 
would likely be less than optimal (Stellingwerff et al. 2014). Similarly, in the present study, 
the incremental test commenced ~3h after supplementation and thus might have not 
corresponded to the optimal NO level. 
Decroix et al. (2017) also reported no influence of acute intake of 900mg of flavanol 
compared to placebo on time to competition of repeated time trials. However, unlike 
Stellingwerff et al. (2014) the time trial commenced at 100 min after ingestion of CFs, 
which coincided with peak plasma EC. Furthermore, this was accompanied with no change 
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in NO biomarkers between conditions. The participants training status in the present study 
was considerably lower compared to Decroix et al. (2017) (Present study - Males 51.1 ± 
3.5, Females 41.6 ± 5.5 Vs. 63 ± 3.5 ml/kg/min), indicating acute supplementation of CFs 
may also not appear to significantly improve performance or NO production in 
recreationally active participants. The beneficial effects on exercise following the 
enhancement via nitrate rich beetroot juice are typically observed after a 2-fold increase in 
plasma nitrite compared to baseline (Bailey et al. 2016; Wylie et al. 2013). Therefore, the 
lack of improvements in plasma nitrite observed in the present study and aforementioned 
may likely be insufficient to evoke any demonstrable physiological effects on performance 
(Decroix et al. 2017). 
It is important to consider the population used within the present study. All regularly 
participated in physical activity and were considered healthy and moderately trained. 
Regular training has been associated with optimised NO production, vascular function, 
energy metabolism and antioxidant (Green et al. 2004). There is growing literature to 
support short-term/sub-chronic consumption of high flavanols doses daily, which may 
potentially accumulate and enhance measures of endothelial functioning, such as flow 
mediated dilation (FMD); an effect that has been shown to be dependent on local NO 
generation (Cooper et al. 2008; Heiss et al. 2007). Longer, 3-month intake of CFs (175mg) 
have been reported to increased V̇O2 max and max watts in sedentary participants compared 
to a placebo, which were attributed to enhanced mitochondrial function and reduced 
oxidative stress (Taub et al. 2016). It is likely that acute supplementation with CFs 
regardless of the concentration may be too small of an effect to actually improve exercise 
performance, particularly within healthy exercising populations. 
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Effects of dietary flavanol supplementation on blood plasma NO3-, NO2-. 
The signalling molecule nitric oxide (NO) is produce by NO synthase (NOS) family of 
enzymes, which are responsible for catalysing the oxidation of L-arginine, yielding NO 
and L-citrulline (Jones 2014). The in vivo quantification of NO is technically challenging: 
therefore changes in the plasma concentration of the oxidation products of NO, namely 
NO2- and NO3 are often measured to provide an indication of NO production (Bailey et al. 
2010).  
 
This study found a linear trend for higher NO2- with higher flavanol concentrations. 
Consumption of HF led to a 1, 9 and 13% increase compared to MF, LF and the CON 
chocolate respectively. However, no acute flavanol concentration corresponded with a 
significant increase in plasma NO2- or NO3-. Plasma NO2- has been reported to better reflect 
region endothelial nitric oxide synthase (eNOS) activity compared to NO3- (Lauer et al. 
2001). This is of interest as the exact mechanistic pathway by which CFs exerts its effect 
is not fully understood but postulated to be the increase in eNOS-dependent NO production 
(Schewe et al. 2008). Most potential explanations for the increase in eNOS-derived NO 
levels, include the modulation in eNOS activity, a change in eNOS substrate availability 
or reduction in the elimination of NO levels (Schewe et al. 2008; Schnorr et al. 2008; 
Steffen et al. 2007). Several well controlled studies have shown acute dietary intervention 
with flavanols can provide beneficial cardiovascular and peripheral effects as a 
consequence of flavanol-induced increases in circulating NO pool as reflected by an 
improvement in endothelial function (Fisher et al. 2003; Heiss et al. 2003; Heiss et al. 2005; 
Schroeter et al. 2006). However, many of these studies have used populations with reduced 
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eNOS or endothelial functioning such as patients who are diabetic, overweight, obese, 
hypertensive, prehypertensive, have coronary artery disease, endothelial dysfunction or 
have higher cardiovascular risk factors (Balzer et al. 2008; Davison et al. 2008; Farouque 
et al. 2006; Grassi et al. 2005b; Lin et al. 2016). The mechanism currently purposed is 
likely to have a greater effect in patients with an increased cardiovascular risk, as eNOS 
activity is reduced compared to that of healthy participants. Moreover, studies have 
demonstrated that cocoa enriched with flavanols improved measures of endothelial 
function to a greater degree in healthy elderly populations than in younger population 
(Fisher and Hollenberg 2006; Heiss et al. 2005; Nehlig 2013). This may be as ageing is 
related to attenuation and in some circumstances the complete loss of endothelium-
dependent vasodilation (Nehlig 2013).  
 
Effects of dietary flavanol supplementation on blood pressure. 
The blood pressure lowering effects of CFs have been reported by many studies 
(Hollenberg et al. 2009; Ried et al. 2017; Ried et al. 2010). Blood pressure was marginally 
influenced by various dosages of CFs concentrations; however, these effects were very 
limited, clearly indicating a single acute dosage of high CFs have minimal effects on 
attenuating blood pressure in healthy active participants. Blood pressure lowering effects 
are significantly stronger in diseased populations and within patients with higher baseline 
blood pressure (Desch et al. 2010; Lin et al. 2016; Ried et al. 2010). Several studies have 
failed to show significant blood pressure lowering effects of flavanols in healthy young 
participants (Desch et al. 2010; Lin et al. 2016; Ried et al. 2010). Some studies have 
demonstrated the capacity for flavanol to attenuate blood pressure in individuals who have 
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been deemed healthy, however these are often in older, overweight or smokers who are 
still likely to have a less than optimal endothelial function (Berry et al. 2010; Heiss and 
Kelm 2010).  
In conclusion, given that CFs intake did not affect cardiorespiratory and blood plasma 
variables during SS and maximal cycling, this study failed to support our hypothesis. It 
appears that within healthy moderately trained participants, the acute addition of various 
concentrations of flavanol DC cannot aid in improving blood plasma NO3- and NO2- or 
enhance exercise capacity and performance. Many studies support the potential 
accumulation of flavanol metabolites if absorbed in high doses daily (Heiss et al. 2007). 
Thus, we propose that acute CF supplementation strategies are ineffective and do not 
provide an ergogenic effect, therefore, further research should focus on short term and 
chronic CF supplementation for enhancing NO bioavailability and exercise capacity in a 
healthy and active population. 
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FIGURE LEGENDS  51 
 52 
Figure 1. Resting systolic blood pressure (SBP) (A) and diastolic blood pressure (DBP) 53 
(B) taken 2h after intake of high flavanol (HF), moderate flavanol (MF), low flavanol 54 
(LF) and control (CON). Values are means ± SD. 55 
Figure 2. Plasma nitrite (NO2-)(A) and nitrate (NO3-) (B) taken 2h after intake of high 56 
flavanol (HF), moderate flavanol (MF), low flavanol (LF) and control (CON) for all 57 
participants; values are means ± SEM.   58 
 59 
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TABLE LEGENDS 51 
 52 
Table 3. Pulmonary gas exchange measures during steady state (SS) and incremental 53 
cycling after high flavanol (HF), moderate flavanol (MF), low flavanol (LF) and control 54 
(CON) intake. 55 
 56 
Table 4. V̇O2 and heart rate responses averaged over the ten-minute recovery phase. Mean 57 
changes in systolic blood pressure (SBP) and diastolic blood pressure (DBP) assessed at 58 
the third and fifth minute during the recovery phase immediately after steady state  cycling. 59 
